Introduction
Obesity is one of the critical risk factors for the development of atherosclerosis, diabetes and coronary artery disease. 1 Previous studies have shown that obesity induces low-grade chronic inflammation in the adipose tissue, 2 leading to dysregulated adipocytokine production and increased oxidative stress. [3] [4] [5] These contribute to the pathogenesis of glucose intolerance, dyslipidemia, and insulin resistance in obesity. To prevent these adverse effects in obese patients, body weight reduction is necessary. While patient education for lifestyle modification and encouragement of physical exercise are recommended to normalize body weight, the effects are often insufficient. Therefore, alternative means to ameliorate obesity have been attempted such as development of anti-obesity drugs. 6 Cannabinoid-1 receptor blocker rimonabant was developed with great expectation, 7 but it has not been commonly used in clinical practices because of several side effects such as depression and anxiety disorder. 8 Thus, a novel therapeutic target to treat obesity has been aspired.
Hypoxia has long been known to reduce body weight in both human 9 and animals. 10, 11 Although hypoxia is shown to suppress fatty acid synthesis and reduce fat mass, 12, 13 the mechanism has not been clarified. Recently, the role of oxygen sensing pathway on metabolism has received much attention. Oxygen sensing pathway consists of a transcription factor, hypoxiainducible factor (HIF) that is a heterodimer of HIF-and HIF-, and an oxygen sensor, prolyl hydroxylase domain protein (PHD). 14 PHD catalyzes oxygen-dependent hydroxylation of the specific proline residues in HIF-subunits, a modification that tags HIF-for rapid polyubiquitination and subsequent proteosomal degradation. Hypoxia increases HIF expression by diminishing PHD activities, thereby activating the expression of divergent target genes involved in metabolism and angiogenesis.
as development of anti-obesity drugs. 6 Cannabinoid-1 receptor blocker rimonaba ban nt nt w w was as as developed with great expectation, 7 but it has not been commonly used in clinical practices be eca ca caus us use e e of of of s se ev ver ral al al s side effects such as depressio o on n n a an nd anxiety diso so order er. . 8 8 T Thus, a novel h h her r rap a eutic targ rge e et t t to tr tr rea ea at t t ob ob obes es esi it ity y ha ha has s b be bee en a asp p pired d d.
Hy Hy ypo po poxi xia a ha ha as s lo lo ong ng g b bee e en n kn kn know ow own n to to o r r re e ed du duce ce ce b b bod d dy y we we eig ig ight ht i i in n n bo bo both th th h h hum um uman an n 9 a a and nd n a an n nim m mal ls s.
Several cell culture studies have revealed that hypoxia and HIF convert cell metabolism dependent on aerobic glucose oxidation and fatty acid synthesis into that dependent on anaerobic glycolysis. HIF not only up-regulates a series of glycolytic enzymes, 15, 16 but also actively inhibits oxidative phosphorylation in mitochondria by inducing pyruvate dehydrogenase kinase 1 (PDK1). 17, 18 PDK1 inhibits pyruvate dehydrogenase activity and consequently reduces conversion of pyruvate to acetyl CoA, an essential substrate for oxidative phosphorylation. 17, 18 Also, HIF inhibits adipogenesis by inducing DEC1/Stra13. 13 These HIF-induced metabolic alterations such as increased glucose consumption and less fatty acid synthesis might be beneficial for nutrient excess in obese or diabetic subjects. Although HIF could be a potential therapeutic target, direct manipulation of HIF is often difficult in vivo. In contrast, PHD is an ideal target to manipulate HIF levels and several chemical inhibitors of PHD have been developed. 19 However, the role of adipocyte PHD in the development of obesity-induced glucose intolerance has not been determined. In the present study, we generated mice lacking PHD2 also known as Egl nine homolog1 (EglN1) in adipocytes, because PHD2 is the most crucial isoform to regulate HIF level in vitro 20 and in vivo 21 among three PHD isoforms (PHD1, PHD2 and PHD3). We found that PHD2 deletion in adipocyte attenuates weight gain and alleviates glucose intolerance induced by a high-fat diet (HFD).
Methods
Additional details of the experimental procedures are included in the online-only Data Supplement.
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Results

PHD2
-deficient mice showed better glucose tolerance after HFD feeding.
PHD2 protein was reduced in WAT and BAT but not in other organs such as lung and skeletal muscle in PHD2-deficient mice (Phd2 f/f /aP2-Cre) ( Figure 1A and Supplemental Figure 1A ).
Expression of PHD2 in heart and bone marrow derived macrophage was slightly reduced. We did not find any apparent abnormalities in the appearance of Phd2 f/f /aP2-Cre mice. Phd2 mRNA cholesterol, triglyceride, insulin, lactate and cytokines were determined by comm m merc rc rcia a all ll lly y y available kits. Oxygen consumption was measured using a computer-controlled open-circuit n ndi di ire re rect ct ct c cal al alor or o im imet et ete er er. . Normality and homoskedas s sti ti tici ity of the data w w were e as as asse s ssed by Shapiro-Wilk e est t a and Leven ne e t te t s st, r re esp sp pec ec ecti ti ive ve vely ly. A A A t t-t tes st or r r e ex xact t b b binom om omia ial l l t te est st w was as u us s sed d d fo fo or r pa pair ir r-w -w -wis ise e e co omp mp mpar ar aris ison on ns. s s. M Mu u ult ti tipl ple e e c co comp mpa ar a is is ison on on w w wa as s p p per er erf f form rm rme ed d d o on o e e-e wa wa way y y or or or t two wo wo-w -w -wa ay ay A A ANO NO NOVA VA V . . Figure 1B) and examined the expression of Phd2 mRNA. Expression of Phd2 mRNA was significantly reduced in an Adipocyte fraction of WAT (Supplemental Figure 1C) .
Expression of Phd2 mRNA was modestly reduced in a SVF, but the difference was not significant. Phd1 mRNA level was not changed and Phd3 mRNA level was increased several fold in WAT of Phd2 f/f /aP2-Cre mice (Supplemental Figure 1D ). Both HIF-1 and HIF-2 proteins were significantly increased in PHD2-deficient WAT ( Figure 1C , Supplemental Figure   1E ), confirming that PHD1 and PHD3 cannot compensate for the absence of PHD2 in terms of HIF-degradation.
Body weight in Phd2
f/f /aP2-Cre mice was slightly lighter than control mice ( Figure 1D ).
After 6 weeks of HFD, Phd2
f/f /aP2-Cre mice gained significantly less body weight than controls.
Since food intake was comparable between the two groups ( Figure 1E ) and we did not find any abnormalities in the feces, these data suggest that Phd2 
Phd2
f/f /aP2-Cre mice showed lower fasting glucose level with a lower insulin concentration and hence a lower homeostasis model assessment-insulin resistance (HOMA-IR) score (Table 1) ,
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mice was slightly lighter than control mice ( r Figure 1D ).
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The number of macrophage aggregation surrounding adipocytes, often referred to as a crown- Since HIF is known to activate glycolytic pathway, 17 (Figure 4D-4G ). In addition, the expression of pyruvate dehydrogenase kinase (Pdk) 1, a rate-limiting enzyme of oxidative phosphorylation, was also significantly upregulated ( Figure 4H ). Dec1 that inhibits adipogenesis 13 was also
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In agreement with the results of in vivo experiments, the expression of Glut1, Pgk1, Gapdh, Ldha and Pdk1 was significantly upregulated in PHD2-deficient 3T3-L1 preadipocytes ( Figure 7D ). After the induction of adipocyte differentiation, the expression of Glut1 was reduced in PHD2-deficient 3T3-L1 adipocytes, whereas expression of other genes was still significantly up-regulated ( Figure 7E ). Both glucose consumption and lactate production in the supernatant were significantly increased in PHD2-deficient 3T3-L1 preadipocytes than control 3T3-L1 preadipocytes ( Figure 7F and 7G), indicating acceleration of glycolysis. We also assessed de novo lipogenesis, because PDK1 suppresses acetyl-CoA production that is essential for fatty acid synthesis. 25 Oil red O staining revealed that PHD2-deficient 3T3-L1 cells accumulated less lipid than control 3T3L-1 cells ( Figure 7H , and I).
Discussion
In this study, we demonstrated that PHD2 deletion in adipocyte alleviates diet-induced obesity and glucose intolerance in mice. PHD2 deletion reduced fat mass and macrophage infiltration into WAT, and increased the expression of UCP-1 in BAT and oxygen consumption, all of which are supposed to be responsible for body weight reduction and better glucose tolerance in HFD- Di Disc sc scus us ussi si sion on on n n t th h his study, w we e d de emo mo ons ns str r tra at ated ed ed t tha ha at t PH PH PHD D D2 d de el e e e etion n n i in ad ad adip ipo ocy yt yte e al alle levi vi ia a ate es s d die ie iet t-t-in indu du duc ce ced d d ob ob bes esit i i y y y an nd d d gl gl gluc uc u os ose e e in i into tole ler ra ranc nc ce e in in m mic ic i e. e e P P PHD HD H 2 2 2 de de dele le letion on on r r red ed duc uc ced ed d f f fat a at m m mas as ass s an an and d ma ma macr crop op opha ha h ge ge ge i i inf nfi i iltr r rat atio io on n nto WAT, an nd d d in in ncr cr crea ea ease se ed d d th h he e e ex e e pr pr pres es e si si sion n n o o of f f UC UC UCP-P-P 1 1 1 in in in B BAT AT AT a a and nd nd o o oxy xy x ge ge gen n n co co cons ns nsum um umpt pt ptio io ion, n, n a a all of which h h While hypoxia has been known to reduce body weight 9 and fat mass, [26] [27] [28] it is intriguing that even PHD2 deletion in adipocyte showed a similar effect. In PHD2-deficient adipocytes, glycolytic pathway becomes dominant due to HIF-induced expression of glucose transporter and glycolytic enzymes, which is often called "aerobic glycolysis." 29 Glycolysis is an inefficient way to produce energy compared to oxidative phosphorylation. Hence, the cells depending on glycolysis consume more glucose "wastefully" compared to those depending on oxidative phosphorylation when both cell types are required to generate an equal amount of ATP. 30 Thereby, PHD2-deficient adipocytes may consume more glucose than normal adipocytes.
Although in vitro study showed that PHD2 knockdown increases lactate production in the supernatant, serum lactate level was rather decreased in Phd2 PHD2 deletion attenuated fatty acid synthesis possibly through Pdk1 up-regulation.
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Phd2
f/f /aP2-Cre mice consumed more oxygen with lower RER and showed reduced lipid content in BAT, which may be explained by up-regulation of Ucp1 expression, at least in part. However, the detailed mechanism for UCP-1 up-regulation is not clear at this point, because UCP-1 is not a target gene of HIF. Overall, PHD2 deletion-associated reprogramming of glucose and lipid metabolism might contribute to obesity-resistance.
It is reported that hypoxia inhibits adipogenesis through up-regulation of DEC1/Stra13. It is reported that Glut 4 expression in skeletal muscle is suppressed in a rat model of insulin resistance, 31 suggesting that Glut 4 up-regulation in Phd2 f/f /aP2-Cre mice may be due to improvement of insulin sensitivity. However, it is not clear how PHD2-deficiency in adipocytes affect skeletal muscle insulin signaling pathway and further study is needed.
It is known that adipose tissues in obese patients are subjected to hypoxia and HIF is accumulated, [32] [33] [34] which is explained by that hypertrophied adipocytes become physically distant from capillaries and inflammatory cells infiltrating into adipose tissue consume a substantial amount of oxygen. However, it has not been determined whether hypoxia in obese adipose plays was increased. However, PPAR expression is rather increased in WAT from Ph hd2 d d2 Figure 4A ). Therefore, it is unlikely that DEC1 is involved in reduced adiposity in Interestingly, HIF-1 and HIF-2 have an opposite effect on adipogenesis; HIF-1 inhibits adipogenesis 13 and HIF-2 promotes it. 37 Therefore, the net effects by PHD2 inhibition on adipose tissue formation may be more complicated than the consequence of a single HIF-1 overexpression. Another possibility is that there may be unidentified substrate(s) of PHD2 for hydroxylation that may be related to glucose and lipid metabolism and inflammation. In contrast, our observation is supported by several lines of evidence from genetically modified mice. 30, 38, 39 Overexpression of dominant negative form of HIF-1 in adipocytes accelerated HFD-induced glucose intolerance and insulin resistance and induced more severe obesity. 38 Another study
showed that factor inhibiting HIF-1 -deficient mice which have elevated HIF activity are also resistant to HFD-induced body weight gain and glucose intolerance. 39 These evidences consistently suggest that HIF signaling is positively linked to resistance to obesity and associated metabolic abnormalities. It is of note that our study revealed that inhibition of PHD2 in adipocytes sufficiently attenuated HFD-induced glucose intolerance and obesity without an increase in serum lactate level, which is observed in SIRT6-deficient mice. 30 Therefore, nterestingly, HIF-1 and HIF-2 have an opposite effect on adipogenesis; HIF--1 1 1 i i inh nh hib ib ibit it its s s adipogenesis 13 and HIF-2 promotes it. 37 Therefore, the net effects by PHD2 inhibition on ad dip ip pos os se e e ti ti tiss ss ssue ue e for or rm ma mation may be more complicat at ted ed e than the cons seq eq e ue enc nc nce e e of a single HIF-1
over erex e pression on. An An Anot othe he h r r r po po pos ss ssib ib ibil ilit it ty y y is i th h hat th th he ere ma ma may b be be u un ni id de ent nti ifi ie ed d su su ub bs str tra at ate e( e(s) s) o o of f f PH PH PHD2 D2 D2 f f for or or f f hy hydr dr d ox ox oxyl yl y at at tio io ion n th that at m ma ay ay b b be e re e ela la l te te ted d d to to to g glu lu l co co cose se se a a and nd n l lip pi pid d d me me meta ta tabo o oli li l sm sm sm a a and nd nd in nf nfla la amm mm mmat at tio io ion n. I I In co con n ntra ra ast s our observat tio io on n n is is s The limitation of the present study is that we have not excluded the possible involvement of PHD2-deficient macrophages, because aP2 gene is known to be expressed in not only adipocytes but also macrophages. 40 However, the reduction of PHD2 expression in BMDM or SVF that is rich in macrophage in Phd2 f/f /aP2-Cre mice was modest and not so remarkable compared with that in adipocytes. Therefore, the effect of PHD2-deletion in macrophage may play a relatively minor role in the reduction of fat mass and improvement of glucose metabolism in Phd2
f/f /aP2-Cre mice.
In conclusion, we showed in this study that PHD2 in adipocytes plays a multifaceted role in the regulation of metabolism and inflammation in diet-induced obesity. Adipocyte-specific
Phd2 deletion ameliorates diet-induced obesity and several obesity-associated metabolic abnormalities. Thus, PHD2 in adipocytes may be a novel target for the treatment of patients with metabolic syndrome. 
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Generation of adipocyte-specific PHD2-deficient mice.
To knockout Phd2 gene in adipocytes, previously generated Phd2-floxed mice were used for two hours at room temperature. Then, the tissues were counterstained with 4',6-diamino-2-phenylindole (DAPI) and examined using the confocal laser scanning microscope A1R (Nikon, Japan). Capillary density was determined by counting blood vessels intersecting 1 mm line drawn in the photos of lectin-stained adipose tissues.
Glucose tolerance test and insulin tolerance test
Mice were starved for 6 hours. 3 For glucose tolerance test, mice were injected intraperitoneally with glucose (1 g/kg of body weight). For insulin tolerance test, mice were injected intraperitoneally with rapid insulin (0.5 IU/kg of body weight). Blood sample was taken from tail vein at various time points and blood glucose concentrations were determined by using Glutest Every (Sanwa Kagaku Kenkyusho, Japan). 
Measurement
Isolation of adipocyte-enriched fraction and stromal vascular fraction (SVF) from white adipose tissues (WAT)
The epididymal fat tissue was minced and digested with collagenase (3 mg/ml, Sigma) in phosphate-buffered saline supplemented with bovine serum albumin (2%, Sigma) at 37 °C for 60 minutes with gentle agitation. Then, the digested fat tissues were filtered through a 250 µm nylon mesh and centrifuged at 430 g for 1 minutes The sediments were used as a SVF and floating cells were used as an adipocyte-enriched fraction after washing with PBS for several times.
Isolation of bone marrow derived macrophages (BMDM).
Bone marrow cells were isolated from femurs and tibias, and were centrifuged (1000rpm, 5 min, 4°C). The sediments were resuspended in DMEM supplemented with 10% FBS and 30% L929 conditioned medium as a source of M-CSF for 7days and attached cells were used as BMDM. After a 1 hour adaptation to the chamber, VO 2 was assed at 4-min intervals for 24 hours. All sample data were analyzed using Oxymax Windows software (version 1.0).
Cell culture
3T3-L1 murine preadipocytes were purchased from Human Science Research Resources Bank (Japan). The cells were maintained in low-glucose DMEM culture medium supplemented with 10 % FBS in an atmosphere of 5 % CO 2 at 37 °C. To differentiate 3T3-L1 preadipocytes into adipocytes, the cells were cultured with high-glucose DMEM containing 10 % FBS, 10 µg/ml insulin, 0.25 µmol/L dexamethasone, and 500 µmol/L isobutylmethylxanthine for two days.
Then, the cells were cultured with fresh high-glucose DMEM containing 10 % FBS and 10 µg/ml insulin for additional two days. After that, the cells were maintained in DMEM containing 10%
FBS for another 8 days.
Gene silencing by retrovirus-mediated small hairpin (sh) RNA expression
Expression vectors of shRNA specific for Phd2 gene were generated using pSINsi-hU6 vector containing the neomycin resistant gene under control of SV40 promoter (Takara Biotechnology, Shiga, Japan). Target DNA sequences for shRNA specific for Phd2 gene were 5'-GCAATAACTGTTTGGTATT-3'. The DNA sequence of control shRNA which had no similarity for any murine genes was 5'-TCAGAACGATGACTGAGAG-3'. The constructs were introduced to Plat-E cells (Cell Biolabs, San Diego, CA, USA) with FuGene6 transfection reagent (Roche Applied Science, Basel, Switzerland). After 48 hours, the culture medium containing retrovirus particles was collected and filtered by passing through 0.45 µm filter (Schleicher&Schuell, Dassel, Germany). Then 3T3-L1 cells were infected with the retrovirus for 24 hours and subsequently selected by G418 (500 µg/ml) treatment for another 7 days.
Oil Red O staining
To determine the extent of lipid accumulation in cytosol, differentiated 3T3-L1 adipocytes were fixed with 10 % formaldehyde for 10 minutes and stained with 0.18 % Oil Red O solution for 15 minutes. After staining, the cells were rinsed with 60% isopropanol. After taking photos, the dye was extracted with 100% isopropanol and absorbance at 520 nm was measured.
RNA extraction and real-time quantitative RT-PCR (qPCR) analysis
RNA from adipose tissue, quadriceps femoris muscle, liver, and cultured cells was extracted using ISOGEN according to manufacturer's instruction (Wako Pure Chemical Industries, Ltd.).
One µg of total RNA was reverse-transcribed using ReverTra Ace qPCR RT Kit (TOYOBO, Osaka, Japan). Real-time qPCR was performed using 7500 real-time PCR system (Life Table 1 .
Measurements of transcriptional activity of HRE-driven promoter
A luciferase construct with 7 copies of hypoxia responsive element (HRE) was a generous gift from Dr. Masaomi Nangaku (University of Tokyo, Japan). The HRE-luciferase vector was introduced to 3T3-L1 preadipocytes by the DEAE-dextran method according to the manufacturer's instructions (Promega Corporation, Madison, WI, U.S.A.). The luciferase activity was measured by Lumat LB9501 (Berthold, Bad Wildbad, Germany) and normalized with protein concentrations.
Statistical analysis
Normality and homoskedasticity of the data were assessed by Shapiro-Wilk test and Levene test, respectively. A t-test was used for comparing two groups. Differences between multiple groups were evaluated using one-way ANOVA followed by Fisher's post hoc test if appropriate.
The data on the number of crown-like structure ( Figure 3C ) and vascular density ( Figure 3I) were assessed by exact binomial test. The data on insulin tolerance test and glucose tolerance test were analyzed by repeated measure two-way ANOVA. Data are shown as mean±SEM.
P<0.05 was considered to be statistically significant. Legends for supplemental figures.
Supplemental table
Supplemental Figure 1
Expression of PHD and HIF in control and Phd2 f/f /aP2-Cre mice.
A, Western blot analysis for PHD2 in heart, bone marrow derived macrophage (BMDM) and A. Glucose tolerance test in control and Phd2 f/f /aP2-Cre mice before high-fat diet feeding.
Glucose tolerance test was performed as indicated in the method. No significant difference was observed between control and Phd2 f/f /aP2-Cre mice.
B. Insulin tolerance test in control and Phd2 f/f /aP2-Cre mice after high-fat diet feeding for 6
weeks.
The results of insulin tolerance test in control and Phd2 f/f /aP2-Cre mice are indicated in actual glucose levels. n=6~7. **P<0.01, *P<0.05 vs control.
Supplemental Figure 3
Serum level of adipokines in control and Phd2 f/f /aP2-Cre mice.
Serum concentrations of MCP-1, IL-6, TNFα and adiponectin were determined by ELISA in high-fat diet fed control and Phd2 f/f /aP2-Cre mice. TNFα was not detectable in both mice and therefore the data are not shown. Although serum MCP-1 level is lower in Phd2 f/f /aP2-Cre mice, the difference was not statistically significant. n=6. N.S.; not significant.
Supplemental Figure 4.
Expression of protein in white adipose tissue (WAT) and skeletal muscle. 
